Varenicline Prescribing Under PGD
Published: 8th January 2026
Recently, we have had several questions asking how to interpret the wording within the Varenicline PGD published as NHS Circular PCP(P)(2025) 06.
Within the PGD, it appears the following paragraph has resulted in some confusion:
“Under PGD legislation there can be no delegation. Supply of the medicine must be by the same practitioner who has assessed the patient under the PGD.”
Only those Pharmacists who have the correct competencies and qualifications as well as meeting the training requirements should work within the PGD, but we have confirmed with colleagues in Scottish Government our understanding that the intention was never for only the initial Pharmacist who carried out the initial patient assessment to be able to make subsequent supplies to an individual.
If this were the case, it could cause an interruption in the supply of Varenicline to the patient (perhaps during Pharmacist absence / annual leave) and also represent a poor patient journey should further assessment or onward referral be required.
For clarity, each individual Varenicline supply does require an assessment by a Pharmacist. This is true whether or not it is the Pharmacist who conducted the initial assessment that makes subsequent supplies, as the patient’s condition may have changed. The recorded detail of the initial assessment can be used to support shorter subsequent consultations and the supply of Varenicline can therefore continue as long as it is still clinically appropriate and possible under the PGD parameters.
If you have any questions, just get in touch at enquiries@cps.scot.
-
It means that only qualified Pharmacists can supply Varenicline under the PGD, but subsequent supplies do not have to be by the same Pharmacist who did the initial assessment.
-
Yes, as long as they carry out an assessment and the supply remains clinically appropriate under PGD parameters.
-
Because the patient’s condition may change, and clinical appropriateness must be confirmed at every supply.
-
Another qualified Pharmacist can assess and supply Varenicline to avoid interruptions in treatment.
-
Email enquiries@cps.scot for support.
Community Pharmacy Scotland (CPS) is delighted to confirm that our 12th annual Charity Golf Day will take place on Friday 4 September.
Your next courier collection is scheduled for Thursday, 5th February. We have produced the following guidelines for your prescription bag submissions.
Our colleagues at the EL Stakeholder Steering Group have asked us to share the following stakeholder engagement questionnaire.
This week’s MCR Ready Reckoner has been updated and is now available to download or you can view it via the App.
CPS Chief Executive Matt Barclay shares what 2026 looks like for Community Pharmacy Scotland and what we will be focusing on over the year ahead.
SSP withdrawal for Adipine® XL modified-release tablets, and Fixapost® preservative-free eye drops, originally due to expire on 6 February 2026, will now be withdrawn early
We are seeking feedback from community pharmacy teams on the Gluten Free Food Service.
PSD will launch its annual Customer Satisfaction Survey on 1 February 2026, and our members are encouraged to take part.
During a recent review of the national EHC service, it was agreed that a specific practice point around the use of Ulipristal should be highlighted.
SSP extensions for Creon 10000 and 25000 have been issued. Pharmacists must review new end dates and continue limiting supply to one month.
On behalf of NHS Health Boards, we are collecting suggestions for amendments to the Approved List from our members and their pharmacy teams, which can be for additions to the list, replacements or deletions.
Our colleagues at Scottish Government have asked us to highlight the recall of specific SMA formula products and, importantly, the associated advice for healthcare teams - please see the attached information sheet for more detail.
Community Pharmacy Scotland will host the next Independent Prescribers meeting on Thursday 5th February 2026. If any independent prescribers in Scotland are planning to attend and have any items you would like to add to the agenda please email us.
The following are the Top Three items currently under discussion and review by your CPS Board. There is no specific detail, yet, as these are currently “works in progress”. Further detail will follow as available.
Our colleagues at Scottish Government have launched he Mind to Mind campaign which encourage people to look after their mental wellbeing. In this article you will find campaign resources that will help you spread the word within your community.
The NHS Pharmacy First Scotland approved product list has been updated for January 2026. Key changes include eczema treatments and cough remedies.
Our 2026 Manifesto calls for investment in infrastructure and integration to enable community pharmacies to deliver life-changing services.
UK pharmacy legislation update: pharmacists can now authorise handing out checked and bagged prescriptions when absent.
If you are a CP Employee starting your CPS/NES Funded IP Course in Jan 2026 at RGU or Strathclyde University, please make sure you have completed and returned the form sent to you by CPS during December.
We are currently reviewing future budgets and training capacity requirements for CPS/NES Funded Employee CPIP Training. To do this, we need a clear picture of how many CP employees in the network have not yet completed their training.
Important update on courier bag changes for prescription collections. Read carefully to avoid delays and ensure correct handling.
Clear guidance on interpreting Varenicline PGD wording from NHS Circular PCP(P)(2025)06 to ensure continuity of supply and patient care.
Review of adjusted prices for January 2026. One line stabilised; continue reporting shortages to help negotiations with Public Health Scotland.
For New Year the office will be closed on 1st and 2nd January 2026 with normal office hours resuming on Monday, 5th January 2026.
Your next courier collection is scheduled for Thursday, 8th January 2026. We have produced the following guidelines for your prescription bag submissions.
SSP 086 for Latanoprost/Timolol eye drops is active 19 Dec 2025–6 Feb 2026. Guidance for pharmacists on substitution and patient care.
SSP 085 for Nifedipine 60mg tablets is active from 19 Dec 2025 to 6 Feb 2026. Guidance for pharmacists on substitution and patient care.
Serious Shortage Protocol for nifedipine (Adipine® XL) 30mg MR tablets in effect from 19 Dec 2025 to 6 Feb 2026. Full guidance for pharmacists.
Update on December 2025 adjusted prices and January 2026 Scottish Drug Tariff Part 7 publishing. Key dates and contact details included.

NHS NSS Practitioner Services (PSD) is running its annual Satisfaction Survey to understand how well its services are working for practitioners and where improvements would be most valuable.